Warburg Pincus has realised around $12bn from investment exits so far this year, matching the record amount returned by the private equity firm across the whole of 2025, according to a report by Reuters.
Clearlake Capital Group has raised $1bn through a collateralised fund obligation (CFO) backed by stakes in its private market funds, after restructuring the transaction following discussions with prospective investors, according to a report by Bloomberg.
Schroders Capital chief executive Georg Wunderlin is set to leave the asset manager as Schroders completes its integration with US-based Nuveen, with group CEO Richard Oldfield expected to take direct responsibility for the private markets business, according to a report by Bloomberg.
Bain Capital is among the private equity firms bidding for Edged, the US data centre developer and operator owned by Koch, in a transaction that could value the business at more than $15bn, according to a report by Bloomberg.
Goldman Sachs’ $18.2bn private credit fund recorded another decline in investor redemption requests during the third quarter, bucking the elevated withdrawal levels reported across much of the private credit market, according to a report by Reuters.
Princeton Equity Group has closed its third flagship private equity fund with $1.3bn in commitments, more than doubling the size of its predecessor as institutional demand drove a heavily oversubscribed fundraise.
Abu Dhabi sovereign investment platform L’imad Capital is preparing to raise capital from external investors for a new investment vehicle focused on private equity and other alternative assets, according to a report by Bloomberg citing unnamed people familiar with the plans.
Private equity and other financial sponsors are increasing their focus on the global sports services industry, with more than 246,000 privately owned companies identified as potential acquisition targets, according to data from Grata.
Indian pharmaceutical company Gujarat Themis Biosyn has secured private credit financing to support its JPY21.5bn ($135m) acquisition of Japanese drugmaker MicroBiopharm Japan, according to a report by Bloomberg.
CVC has ended its pursuit of Bodycote, removing the final competing bid for the UK-listed thermal processing specialist and leaving Veritas Capital on track to complete its £1.85bn ($2.45bn) acquisition, including debt, according to a report by Reuters.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
